Yasushi Miyazaki Selected Research

Leukemia

11/2021	Optimal treatment for Philadelphia-negative acute lymphoblastic leukemia in first remission in the era of high-intensity chemotherapy.
3/2021	Combination of clofarabine, etoposide, and cyclophosphamide in adult relapsed/refractory acute lymphoblastic leukemia: a phase 1/2 dose-escalation study by the Japan Adult Leukemia Study Group.
12/2020	Predictors of early death, serious hemorrhage, and differentiation syndrome in Japanese patients with acute promyelocytic leukemia.
9/2020	Real-world management of infection during chemotherapy for acute leukemia in Japan: from the results of a nationwide questionnaire-based survey by the Japan Adult Leukemia Study Group.
7/2020	Targeting MEF2D-fusion Oncogenic Transcriptional Circuitries in B-cell Precursor Acute Lymphoblastic Leukemia.
12/2018	Allogeneic hematopoietic stem cell transplantation for the treatment of BCR-ABL1-negative atypical chronic myeloid leukemia and chronic neutrophil leukemia: A retrospective nationwide study in Japan.
12/2018	Infectious complications in adults undergoing intensive chemotherapy for acute myeloid leukemia in 2001-2005 using the Japan Adult Leukemia Study Group AML201 protocols.
9/2018	Final analysis of the JALSG Ph+ALL202 study: tyrosine kinase inhibitor-combined chemotherapy for Ph+ALL.
11/2017	Management of infection during chemotherapy for acute leukemia in Japan: a nationwide questionnaire-based survey by the Japan Adult Leukemia Study Group.
2/2016	Impacts of graft-versus-host disease on outcomes after allogeneic hematopoietic stem cell transplantation for chronic myelomonocytic leukemia: A nationwide retrospective study.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yasushi Miyazaki Research Topics

Disease

31	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2022 - 10/2003
26	Neoplasms (Cancer) 02/2022 - 10/2002
26	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 02/2022 - 08/2010
25	Leukemia 11/2021 - 09/2004
24	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 10/2022 - 09/2004
15	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022 - 01/2006
14	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 11/2021 - 02/2007
11	Philadelphia Chromosome 01/2022 - 02/2008
7	Febrile Neutropenia 01/2022 - 07/2011
7	Infections 09/2020 - 11/2006
6	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2022 - 03/2012
6	Acute Promyelocytic Leukemia 12/2020 - 03/2007
5	Thrombocytopenia (Thrombopenia) 05/2022 - 10/2003
5	Neutropenia 05/2022 - 07/2011
5	Lymphoma (Lymphomas) 10/2020 - 03/2004
5	Pathologic Complete Response 02/2016 - 01/2006
4	Hematologic Neoplasms (Hematological Malignancy) 06/2022 - 01/2019
4	Disease Progression 08/2021 - 03/2004
4	Bronchiolitis Obliterans Syndrome 01/2019 - 01/2018
3	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 05/2022 - 02/2016
3	Residual Neoplasm 01/2022 - 11/2008
3	Pneumonia (Pneumonitis) 08/2021 - 03/2007
3	Hemorrhage 12/2020 - 03/2007
3	Chromosome Aberrations (Chromosome Abnormalities) 02/2020 - 01/2003
2	Erythema 01/2022 - 01/2019
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2022 - 01/2019
2	Mycosis Fungoides 01/2022 - 12/2008
2	Candidiasis (Moniliasis) 08/2021 - 06/2015
2	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 03/2021 - 07/2007
2	Hodgkin Disease (Hodgkin's Disease) 03/2021 - 01/2017
2	Leukocytosis (Pleocytosis) 12/2020 - 10/2003
2	Wilms Tumor (Wilm's Tumor) 10/2020 - 01/2016
2	Adenocarcinoma 10/2020 - 06/2011
2	Peripheral Nervous System Diseases (PNS Diseases) 01/2020 - 08/2014
2	Invasive Pulmonary Aspergillosis 01/2020 - 12/2018
2	Dyspnea (Shortness of Breath) 01/2020 - 01/2019
2	Lymphadenopathy 04/2019 - 01/2017
2	Membranous Glomerulonephritis (Membranous Nephropathy) 01/2019 - 02/2004
2	Multiple Myeloma 01/2019 - 08/2014
2	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2019 - 01/2017
2	Fever (Fevers) 11/2017 - 11/2006
2	Primary Myelofibrosis (Myelosclerosis) 11/2016 - 01/2016
2	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 02/2016 - 11/2006
2	Carcinogenesis 12/2014 - 05/2011

Drug/Important Bio-Agent (IBA)

19	Imatinib Mesylate (Gleevec)FDA Link 01/2022 - 01/2006
8	Azacitidine (5 Azacytidine)FDA Link 08/2022 - 10/2014
6	Cytarabine (Cytosar-U)FDA LinkGeneric 06/2022 - 03/2010
6	Tretinoin (Retinoic Acid)FDA LinkGeneric 12/2020 - 03/2007
6	Proteins (Proteins, Gene)FDA Link 10/2020 - 10/2002
5	Tyrosine Kinase InhibitorsIBA 11/2021 - 04/2012
4	Pharmaceutical PreparationsIBA 05/2022 - 10/2003
4	SteroidsIBA 01/2022 - 01/2018
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022 - 11/2014
4	mogamulizumabIBA 10/2020 - 04/2015
4	Transcription Factors (Transcription Factor)IBA 07/2020 - 02/2011
3	Phosphotransferases (Kinase)IBA 05/2022 - 01/2014
3	Prednisolone (Predate)FDA LinkGeneric 01/2022 - 10/2003
3	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2021 - 10/2010
3	LigandsIBA 12/2020 - 01/2016
3	Biological ProductsIBA 10/2020 - 01/2003
3	Anti-Bacterial Agents (Antibiotics)IBA 09/2020 - 11/2017
3	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 09/2020 - 09/2015
3	Lenalidomide (CC 5013)FDA Link 04/2020 - 08/2014
3	Immunoglobulin G (IgG)IBA 01/2019 - 11/2006
3	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 09/2004
3	Messenger RNA (mRNA)IBA 01/2016 - 03/2013
2	Daunorubicin (Cerubidine)FDA LinkGeneric 06/2022 - 02/2011
2	BI 6727IBA 05/2022 - 11/2015
2	Heat-Shock Proteins (Heat-Shock Protein)IBA 02/2022 - 12/2014
2	venetoclaxIBA 01/2022 - 08/2021
2	Dasatinib (BMS 354825)FDA Link 01/2022 - 04/2009
2	Biomarkers (Surrogate Marker)IBA 11/2021 - 12/2017
2	Etoposide (VP 16)FDA LinkGeneric 03/2021 - 11/2014
2	Peptides (Polypeptides)IBA 10/2020 - 12/2017
2	Mucin-1 (CA 15-3 Antigen)IBA 10/2020 - 06/2011
2	FluoroquinolonesIBA 09/2020 - 12/2018
2	Dexamethasone (Maxidex)FDA LinkGeneric 01/2020 - 08/2014
2	Tacrolimus (Prograf)FDA LinkGeneric 11/2019 - 01/2019
2	Ferritins (Ferritin)IBA 11/2019 - 09/2012
2	IronIBA 11/2019 - 07/2008
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 03/2019 - 12/2013
2	AntigensIBA 01/2019 - 12/2018
2	tamibaroteneIBA 01/2019 - 11/2014
2	Peroxidase (Myeloperoxidase)IBA 01/2018 - 09/2006
2	Creatine Kinase (Creatine Phosphokinase)IBA 12/2017 - 02/2007
2	Inosine Triphosphate (ITP)IBA 02/2016 - 11/2006

Therapy/Procedure

40	Therapeutics 10/2022 - 09/2004
30	Hematopoietic Stem Cell Transplantation 10/2022 - 02/2004
30	Drug Therapy (Chemotherapy) 08/2022 - 10/2003
16	Transplantation 01/2022 - 03/2004
7	Remission Induction 12/2020 - 01/2006
7	Cell Transplantation 01/2020 - 03/2012
7	Stem Cell Transplantation 01/2020 - 02/2004
6	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2022 - 03/2004
3	Induction Chemotherapy 09/2020 - 03/2010
3	Radiotherapy 01/2019 - 01/2017
2	Liver Transplantation 10/2020 - 01/2019
2	Activities of Daily Living (ADL) 01/2019 - 09/2004
2	Consolidation Chemotherapy 12/2018 - 02/2011
2	Salvage Therapy 08/2018 - 12/2013